FTRE
What one share of Fortrea Holdings holds
Services – Medical Laboratories
Fortrea Holdings Inc. is a leading global contract research organization (“CRO”), providing biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology and medical device customers.
Fortrea Holdings’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $28.74 |
|---|---|
| Profit | −$0.91 |
| Capex (buildings and equipment) | $0.34 |
| Free cash flow | $2.10 |
| Cash and investments | $1.77 |
| Debt | $11.09 |
| Book value | $5.51 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2021 | $34.43 | $1.10 | $0.30 | $1.61 | — | $36.73 |
| 2022 | $31.95 | $2.10 | $0.61 | $0.32 | — | — |
| 2023 | $32.01 | −$0.28 | $0.45 | $1.44 | — | $19.30 |
| 2024 | $30.13 | −$3.67 | $0.28 | $2.65 | — | $15.19 |
| 2025 | $29.85 | −$10.81 | $0.28 | $0.97 | — | $6.05 |